G&E Herbal Biotechnology Co., Ltd. 4911.TWO Stock
G&E Herbal Biotechnology Co., Ltd. Price Chart
G&E Herbal Biotechnology Co., Ltd. 4911.TWO Financial and Trading Overview
| G&E Herbal Biotechnology Co., Ltd. stock price | 60.5 TWD |
| Previous Close | 75.1 TWD |
| Open | 75.7 TWD |
| Bid | 74.5 TWD x 0 |
| Ask | 74.6 TWD x 0 |
| Day's Range | 74.6 - 75.7 TWD |
| 52 Week Range | 39 - 83.5 TWD |
| Volume | 93.58K TWD |
| Avg. Volume | 356.51K TWD |
| Market Cap | 4.15B TWD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 152.24489 |
| EPS (TTM) | 1.32 TWD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | August 25, 2015 |
| 1y Target Est | N/A |
4911.TWO Valuation Measures
| Enterprise Value | 4.2B TWD |
| Trailing P/E | 152.24489 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 6.0103126 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
G&E Herbal Biotechnology Co., Ltd. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 50.20% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 83.5 TWD |
| 52 Week Low | 39 TWD |
| 50-Day Moving Average | 73.69 TWD |
| 200-Day Moving Average | 60.08 TWD |
4911.TWO Share Statistics
| Avg. Volume (3 month) | 356.51K TWD |
| Avg. Daily Volume (10-Days) | 301.9K TWD |
| Shares Outstanding | 55.66M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 50.42% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1012:1000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | 1.16 TWD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | 0.49 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 12.412 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of G&E Herbal Biotechnology Co., Ltd.
| Country | Taiwan |
| State | N/A |
| City | Tainan City |
| Address | No.92, Keji 5th Road |
| ZIP | 70955 |
| Phone | 886 6 384 0890 |
| Website | https://www.geherbs.com.tw |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 34 |
G&E Herbal Biotechnology Co., Ltd., a biotechnology company, focuses on the development and commercialization of novel botanical extraction technology and products in Taiwan. It offers hepato protective agent capsules for the treatment of chronic liver inflammation, cirrhosis, hepatitis, and other liver diseases; botanical anti-aging cosmetic products, such as foam cleanser, botanical extract toner, moisture conditioning cream, and whitening clear cream; and SR-100 skin repair gel. The company also provides botanical healthcare products comprising ArthrEnergy, Jujubes Polysaccharide, Diabecut, HepatoClean, Astragali Radix, Goji, Prosta, and SR-100 capsules; and adult products. In addition, it is developing Solarise injection for the treatment of gynecological, head, and neck cancer; Apocin capsule to treat non-small cell lung cancer; and SR-T100 Gel for the treatment of common and genital warts. Further, the company manufactures technology development for various dietary supplements, as well as provides technical advisory services to other biotechnology organizations. G&E Herbal Biotechnology Co., Ltd. was founded in 2002 and is based in Tainan City, Taiwan.
Q&A For G&E Herbal Biotechnology Co., Ltd. Stock
What is a current 4911.TWO stock price?
G&E Herbal Biotechnology Co., Ltd. 4911.TWO stock price today per share is 60.5 TWD.
How to purchase G&E Herbal Biotechnology Co., Ltd. stock?
You can buy 4911.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for G&E Herbal Biotechnology Co., Ltd.?
The stock symbol or ticker of G&E Herbal Biotechnology Co., Ltd. is 4911.TWO.
Which industry does the G&E Herbal Biotechnology Co., Ltd. company belong to?
The G&E Herbal Biotechnology Co., Ltd. industry is Biotechnology.
How many shares does G&E Herbal Biotechnology Co., Ltd. have in circulation?
The max supply of G&E Herbal Biotechnology Co., Ltd. shares is 55.66M.
What is G&E Herbal Biotechnology Co., Ltd. Price to Earnings Ratio (PE Ratio)?
G&E Herbal Biotechnology Co., Ltd. PE Ratio is 45.83333200 now.
What was G&E Herbal Biotechnology Co., Ltd. earnings per share over the trailing 12 months (TTM)?
G&E Herbal Biotechnology Co., Ltd. EPS is 1.32 TWD over the trailing 12 months.
Which sector does the G&E Herbal Biotechnology Co., Ltd. company belong to?
The G&E Herbal Biotechnology Co., Ltd. sector is Healthcare.